• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EVE
Click for more information
0.00% 0.1¢

EVE HEALTH GROUP LIMITED. - Announcements

Market Cap $5.274M  ! watchlist Created with Sketch. Add to my watchlist

EVE Health Group Limited is an Australia-based vertically integrated producer of branded... EVE Health Group Limited is an Australia-based vertically integrated producer of branded nutrition, health and wellness products. The Company’s Meluka business provides branded wellness consumer products. Its Meluka business is focused on supporting sales of its digestive health products, in particular the P3 Gut Builder. It provides probiotic supplement powder system for improved digestive health. The functional gut nutrition solution is in the form of a three-step supplement powder system, each of which contain pre, pro and postbiotics as well as selected functional superfood ingredients in an easy to consume and versatile offering. The Company also offers honey and essential oil products. Its honey products include organic raw honey and raw honey probiotic concentrate. The Company has global reach and application to various markets across Australia and New Zealand, Asia Pacific and North America.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
EVE Appendix 3B26/03/19
EVE PlacementPRICE SENSITIVE26/03/19
EVE Meluka Honey US Update18/03/19
EVE Meluka Honey Appoints OpenDNA (Revised)15/03/19
EVE OPN: OPN's RooLife to sell EVE's Meluka Honey in China12/03/19
EVE Meluka Honey Appoints OpenDNA for Chinese Market EntryPRICE SENSITIVE12/03/19
EVE Appendix 4D and Half Year ReportPRICE SENSITIVE01/03/19
EVE Appendix 3B25/02/19
EVE EVE to Acquire Remaining 50% of Meluka HealthPRICE SENSITIVE25/02/19
EVE Response to ASX Appendix 4C QueryPRICE SENSITIVE19/02/19
EVE Quarterly ReviewPRICE SENSITIVE31/01/19
EVE Appendix 3B31/12/18
EVE Appendix 3B22/11/18
EVE Appendix 3Y22/11/18
EVE Results of Annual General Meeting22/11/18
EVE Presentation22/11/18
EVE Meluka Honey Secures Distribution for NSW & ACTPRICE SENSITIVE14/11/18
EVE Change of Director's Interest Notice12/11/18
EVE Southern Cross University Media Release09/11/18
EVE Meluka Honey Combines Anti-Microbial & Anti-Oxidant ActivityPRICE SENSITIVE08/11/18
EVE Quarterly ReviewPRICE SENSITIVE25/10/18
EVE Notice of Annual General Meeting and Proxy Form19/10/18
EVE Appendix 4G and Corporate Governance Statement19/10/18
EVE Annual Report to Shareholders19/10/18
EVE Notice of change of interests of substantial holder18/10/18
EVE Presentation12/09/18
EVE Omni Innovation - Update by Eagle Health12/09/18
EVE Appendix 4E and Full Year Statutory AccountsPRICE SENSITIVE31/08/18
EVE Completion of Jenbrook Transaction30/08/18
EVE Appendix 3B30/08/18
EVE ProspectusPRICE SENSITIVE30/08/18
EVE Results of General Meeting24/08/18
EVE Quarterly ReviewPRICE SENSITIVE25/07/18
EVE Completion of THC AgreementsPRICE SENSITIVE24/07/18
EVE Notice of General Meeting/Proxy Form23/07/18
EVE Omni Innovation - Update by Eagle Health on Chinese MarketPRICE SENSITIVE16/07/18
EVE THC: Due Diligence Period Extended For Organic Cannabis Site03/07/18
EVE Update on THC AgreementsPRICE SENSITIVE03/07/18
EVE Appendix 3B27/06/18
EVE EVE to Acquire Leading Aust Organic Tea Tree Oil ProducerPRICE SENSITIVE21/06/18
EVE Trading HaltPRICE SENSITIVE19/06/18
EVE Eagle Plans to Significantly Expand China Distribution31/05/18
EVE Corporate Update29/05/18
EVE Meluka Health and THC Execute Term Sheet03/05/18
EVE THC: Secures Additional Site for Medicinal Cannabis GrowthPRICE SENSITIVE03/05/18
EVE Quarterly ReviewPRICE SENSITIVE30/04/18
EVE First Quarter China Sales ProgressPRICE SENSITIVE26/04/18
EVE Net Tangible Asset Backing05/04/18
EVE Change of Director's Interest Notice x 404/04/18
EVE Appendix 3B04/04/18
EVE Allotment of Rights Issue Shortfall28/03/18
EVE Net Tangible Asset Backing13/03/18
EVE Investor Presentation13/03/18
EVE Completion of Rights Issue05/03/18
EVE Half Yearly Report and AccountsPRICE SENSITIVE26/02/18
EVE Meluka Consumer Products Launch at US Natural Products ExpoPRICE SENSITIVE23/02/18
EVE Rights Issue Offer DocumentPRICE SENSITIVE19/02/18
EVE Omni Innovation - Update by Eagle on Chinese Rollout14/02/18
EVE Net Tangible Asset Backing13/02/18
EVE Eagle Commences Marketing and Sales in China13/02/18
EVE Letter to Shareholders12/02/18
EVE Letter to Optionholders09/02/18
EVE Appendix 3B and Section 708AA(2)(f) Notice09/02/18
EVE Non-Renounceable Rights Offer09/02/18
EVE Appendix 3B08/02/18
EVE Appendix 3B07/02/18
EVE ProspectusPRICE SENSITIVE06/02/18
EVE Capital Raising Update06/02/18
EVE Quarterly ReviewPRICE SENSITIVE31/01/18
EVE Appendix 3B31/01/18
EVE Change to Board Roles31/01/18
EVE Oversubscribed Placement & Rights Issue to Raise up to $6.3mPRICE SENSITIVE31/01/18
EVE Trading HaltPRICE SENSITIVE25/01/18
EVE Appendix 3B18/01/18
EVE Net Tangible Asset Backing12/01/18
EVE Change of Director's Interest Notice x 429/12/17
EVE Appendix 3B29/12/17
EVE Appendix 3B15/12/17
EVE Net Tangible Asset Backing13/12/17
EVE Appendix 3B08/12/17
EVE Eagle Begins Shipment of Omni Innovation's Diabetes ProductPRICE SENSITIVE08/12/17
EVE Meluka Health to Develop Honey Water for Chinese MarketPRICE SENSITIVE07/12/17
EVE Eve Completes 50% Investment in Meluka HealthPRICE SENSITIVE06/12/17
EVE Change of Director's Interest Notice x 201/12/17
EVE Appendix 3B01/12/17
EVE Response to ASX Price & Volume QueryPRICE SENSITIVE30/11/17
EVE Change of Director's Interest Notice27/11/17
EVE Appendix 3B27/11/17
EVE NSW Grant for Honey Research SuccessfulPRICE SENSITIVE27/11/17
EVE Appendix 3Y23/11/17
EVE Appendix 3B22/11/17
EVE ProspectusPRICE SENSITIVE22/11/17
EVE Results of Annual General Meeting22/11/17
EVE Medic Honey Produces a Hemp Seed HoneyPRICE SENSITIVE22/11/17
EVE Sydney Investor Roadshow Presentation15/11/17
EVE Net Tangible Asset Backing14/11/17
EVE Philip Owens Appointed CEO of Omni Innovation13/11/17
EVE Meluka Honey Branding and Marketing Commences09/11/17
EVE Supply Agmt with Large Producer of Australian Organic HoneyPRICE SENSITIVE06/11/17
EVE Meluka Health Appoints Leading Bee And Honey Advisor02/11/17
EVE Appendix 3B
26/03/19
EVE Placement
26/03/19PRICE SENSITIVE
EVE Meluka Honey US Update
18/03/19
EVE Meluka Honey Appoints OpenDNA (Revised)
15/03/19
EVE OPN: OPN's RooLife to sell EVE's Meluka Honey in China
12/03/19
EVE Meluka Honey Appoints OpenDNA for Chinese Market Entry
12/03/19PRICE SENSITIVE
EVE Appendix 4D and Half Year Report
01/03/19PRICE SENSITIVE
EVE Appendix 3B
25/02/19
EVE EVE to Acquire Remaining 50% of Meluka Health
25/02/19PRICE SENSITIVE
EVE Response to ASX Appendix 4C Query
19/02/19PRICE SENSITIVE
EVE Quarterly Review
31/01/19PRICE SENSITIVE
EVE Appendix 3B
31/12/18
EVE Appendix 3B
22/11/18
EVE Appendix 3Y
22/11/18
EVE Results of Annual General Meeting
22/11/18
EVE Presentation
22/11/18
EVE Meluka Honey Secures Distribution for NSW & ACT
14/11/18PRICE SENSITIVE
EVE Change of Director's Interest Notice
12/11/18
EVE Southern Cross University Media Release
09/11/18
EVE Meluka Honey Combines Anti-Microbial & Anti-Oxidant Activity
08/11/18PRICE SENSITIVE
EVE Quarterly Review
25/10/18PRICE SENSITIVE
EVE Notice of Annual General Meeting and Proxy Form
19/10/18
EVE Appendix 4G and Corporate Governance Statement
19/10/18
EVE Annual Report to Shareholders
19/10/18
EVE Notice of change of interests of substantial holder
18/10/18
EVE Presentation
12/09/18
EVE Omni Innovation - Update by Eagle Health
12/09/18
EVE Appendix 4E and Full Year Statutory Accounts
31/08/18PRICE SENSITIVE
EVE Completion of Jenbrook Transaction
30/08/18
EVE Appendix 3B
30/08/18
EVE Prospectus
30/08/18PRICE SENSITIVE
EVE Results of General Meeting
24/08/18
EVE Quarterly Review
25/07/18PRICE SENSITIVE
EVE Completion of THC Agreements
24/07/18PRICE SENSITIVE
EVE Notice of General Meeting/Proxy Form
23/07/18
EVE Omni Innovation - Update by Eagle Health on Chinese Market
16/07/18PRICE SENSITIVE
EVE THC: Due Diligence Period Extended For Organic Cannabis Site
03/07/18
EVE Update on THC Agreements
03/07/18PRICE SENSITIVE
EVE Appendix 3B
27/06/18
EVE EVE to Acquire Leading Aust Organic Tea Tree Oil Producer
21/06/18PRICE SENSITIVE
EVE Trading Halt
19/06/18PRICE SENSITIVE
EVE Eagle Plans to Significantly Expand China Distribution
31/05/18
EVE Corporate Update
29/05/18
EVE Meluka Health and THC Execute Term Sheet
03/05/18
EVE THC: Secures Additional Site for Medicinal Cannabis Growth
03/05/18PRICE SENSITIVE
EVE Quarterly Review
30/04/18PRICE SENSITIVE
EVE First Quarter China Sales Progress
26/04/18PRICE SENSITIVE
EVE Net Tangible Asset Backing
05/04/18
EVE Change of Director's Interest Notice x 4
04/04/18
EVE Appendix 3B
04/04/18
EVE Allotment of Rights Issue Shortfall
28/03/18
EVE Net Tangible Asset Backing
13/03/18
EVE Investor Presentation
13/03/18
EVE Completion of Rights Issue
05/03/18
EVE Half Yearly Report and Accounts
26/02/18PRICE SENSITIVE
EVE Meluka Consumer Products Launch at US Natural Products Expo
23/02/18PRICE SENSITIVE
EVE Rights Issue Offer Document
19/02/18PRICE SENSITIVE
EVE Omni Innovation - Update by Eagle on Chinese Rollout
14/02/18
EVE Net Tangible Asset Backing
13/02/18
EVE Eagle Commences Marketing and Sales in China
13/02/18
EVE Letter to Shareholders
12/02/18
EVE Letter to Optionholders
09/02/18
EVE Appendix 3B and Section 708AA(2)(f) Notice
09/02/18
EVE Non-Renounceable Rights Offer
09/02/18
EVE Appendix 3B
08/02/18
EVE Appendix 3B
07/02/18
EVE Prospectus
06/02/18PRICE SENSITIVE
EVE Capital Raising Update
06/02/18
EVE Quarterly Review
31/01/18PRICE SENSITIVE
EVE Appendix 3B
31/01/18
EVE Change to Board Roles
31/01/18
EVE Oversubscribed Placement & Rights Issue to Raise up to $6.3m
31/01/18PRICE SENSITIVE
EVE Trading Halt
25/01/18PRICE SENSITIVE
EVE Appendix 3B
18/01/18
EVE Net Tangible Asset Backing
12/01/18
EVE Change of Director's Interest Notice x 4
29/12/17
EVE Appendix 3B
29/12/17
EVE Appendix 3B
15/12/17
EVE Net Tangible Asset Backing
13/12/17
EVE Appendix 3B
08/12/17
EVE Eagle Begins Shipment of Omni Innovation's Diabetes Product
08/12/17PRICE SENSITIVE
EVE Meluka Health to Develop Honey Water for Chinese Market
07/12/17PRICE SENSITIVE
EVE Eve Completes 50% Investment in Meluka Health
06/12/17PRICE SENSITIVE
EVE Change of Director's Interest Notice x 2
01/12/17
EVE Appendix 3B
01/12/17
EVE Response to ASX Price & Volume Query
30/11/17PRICE SENSITIVE
EVE Change of Director's Interest Notice
27/11/17
EVE Appendix 3B
27/11/17
EVE NSW Grant for Honey Research Successful
27/11/17PRICE SENSITIVE
EVE Appendix 3Y
23/11/17
EVE Appendix 3B
22/11/17
EVE Prospectus
22/11/17PRICE SENSITIVE
EVE Results of Annual General Meeting
22/11/17
EVE Medic Honey Produces a Hemp Seed Honey
22/11/17PRICE SENSITIVE
EVE Sydney Investor Roadshow Presentation
15/11/17
EVE Net Tangible Asset Backing
14/11/17
EVE Philip Owens Appointed CEO of Omni Innovation
13/11/17
EVE Meluka Honey Branding and Marketing Commences
09/11/17
EVE Supply Agmt with Large Producer of Australian Organic Honey
06/11/17PRICE SENSITIVE
EVE Meluka Health Appoints Leading Bee And Honey Advisor
02/11/17
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
0.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $5.274M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
EVE (ASX) Chart

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.